KUTOK JEFFERY (Chief Scientific Officer) sold 2.6% of their position (2.56K shares) of EPIZYME, INC. on the open market
Open‑market sale worth $3.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2022ACC: 0000899243-22-004827
Officer· Chief Scientific Officer
Since Apr 2020
-2.56K
Net shares
Net seller
$3.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.56K disposed
Non-Derivative Transactions1
Common Stock, par value $0.0001
Direct
Shares
−2.56K
Price / share
$1.37
Trade value
$3.50K
% of position
2.6%
2/2/2022
99.86K→97.30K
Total
Net shares
−2.56K
Net value
-$3.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 Direct | 2/2/2022 | S · Sale | −2.56K | $1.37 | $3.50K | 2.6% | 99.86K | 97.30K |
| Total | −2.56K | -$3.50K | ||||||
Derivative Transactions0
No derivative transactions reported